Brief: Merck KGaA Now Expects Organic Growth Of 4% To 8%
Aug 7 (Reuters) - Merck KGaA MRCG.DE: MERCK KGAA - Q2 NET SALES EUR 5.3 BILLION MERCK KGAA - Q2 EBITDA PRE EUR 1.46 BILLION MERCK KGAA - OUTLOOK 2025 NARROWED EXPECTED ORGANIC SALES GROWTH RANGE FOR THE GROUP TO 2% TO 5% (PREVIOUS 2% TO 6%) MERCK KGAA - OUTLOOK 2025 EBITDA PRE, MERCK RAISED ITS GUIDANCE AND NOW EXPECTS ORGANIC GROWTH OF 4% TO 8% (PREVIOUS 2% TO 7%) Further company coverage: MRCG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Merck KGaA
See all newsUS stocks weekly: AI reality
US stocks weekly: AI reality
Brief: Bio-Techne Co Will Be Required To Pay To Merck KGaA Termination Fee Equal To $230.5 Million If Deal Terminated Under Certain Circumstances - SEC Filing
Press Digest: Financial Times - June 26
US STOCKS-Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook